Home Information Management Data Analysis Creating a Clinical Crystal Ball: SOPHiA Genetics is Democratizing Data-Driven Medicine

Jurgi Camblong 2 — SOPHiA Genetics CEO Jurgi Camblong, PhD, says the company is about halfway through its mission of connecting 780 hospitals around the world in 72 countries: "This speaks to our view of the world and on the democratization of these approaches." [SOPHiA Genetics]

Creating a Clinical Crystal Ball: SOPHiA Genetics is Democratizing Data-Driven Medicine

CEO Jurgi Camblong discusses the international company’s platform that enables healthcare professionals to leverage their expertise and work together across the world.

By Jonathan Grinstein, PhD

August 9, 2021

SOPHiA Genetics CEO Jurgi Camblong, PhD, says the company is about halfway through its mission of connecting 780 hospitals around the world in 72 countries: "This speaks to our view of the world and on the democratization of these approaches." [SOPHiA Genetics]

SOPHiA Genetics is the creator of a global data pooling and knowledge-sharing platform that advances data-driven medicine, working with customers from more than 780 institutions in more than 70 countries. The goal of this data-driven medicinal network is to improve health outcomes and economics worldwide. On July 22, SOPHiA Genetics announced the pricing of its initial public offering (Nasdaq: SOPH) of 13 million ordinary shares at $18 per share . . .